MedPath

Abdominal and thoracic ultrasound for the diagnosis of pulmonary and extra-pulmonary tuberculosis. Assessing the accuracy of point-of-care ultrasound for the diagnosis and therapy monitoring in patients with presumed tuberculosis in India and Germany

Conditions
A18
Tuberculosis of other organs
Registration Number
DRKS00026636
Lead Sponsor
Deutsches Zentrum für Infektionsforschung
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
710
Inclusion Criteria

patients aged 18 years or older
-presenting with: clinical constellation compatible with pulmonary TB (PTB) and/or extra-pulmonary (EPTB)
-AND TB presumed to be highly likely differential diagnosis due to clinical, radiological, laboratory information
-AND at least one of the symptoms below suggestive of TB (as defined by WHO):
oCurrent cough of 2 weeks or of any duration in PLHIV
oNight sweats
oFever
oWeight loss
-Willingness to have a study follow-up visit at 2-3 months after enrolment (e.g. not planning to relocate).
-if considered for follow-up study: willingness to have follow-up visits at 1, 2, 4, 6 months of anti-TB treatment

Exclusion Criteria

-no consent given
-confirmed diagnosis of TB by sample >14 days ago (by sputum microscopy, culture, PCR)
-on anti-tuberculous (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol, Quinolones) for more than 24 hours
-on anti-tuberculous treatment (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol, Quinolones) in past 60 days
-on preventive therapy for TB infection within the past 6 months

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
diagnostic accuracy of single ultrasound findings as compared to the reference standard
Secondary Outcome Measures
NameTimeMethod
evolution of ultrasound findings under anti-TB therapy
© Copyright 2025. All Rights Reserved by MedPath